BioNexus Gene Lab Corp Common stock (BGLC)vsSociedad Quimica y Minera de Chile SA ADR B (SQM)
BGLC
BioNexus Gene Lab Corp Common stock
$2.20
-4.14%
BASIC MATERIALS · Cap: $5.56M
SQM
Sociedad Quimica y Minera de Chile SA ADR B
$75.43
-2.91%
BASIC MATERIALS · Cap: $21.61B
Smart Verdict
WallStSmart Research — data-driven comparison
Sociedad Quimica y Minera de Chile SA ADR B generates 99693% more annual revenue ($5.30B vs $5.31M). SQM leads profitability with a 15.4% profit margin vs -54.7%. SQM earns a higher WallStSmart Score of 74/100 (B).
BGLC
Avoid26
out of 100
Grade: F
SQM
Strong Buy74
out of 100
Grade: B
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Strong operational efficiency at 41.1%
Revenue surging 69.8% year-over-year
Earnings expanding 165.2% YoY
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -35.9% — below average capital efficiency
Revenue declined 98.9%
Moderate valuation
Comparative Analysis Report
WallStSmart ResearchBull Case : BGLC
The strongest argument for BGLC centers on Price/Book, Debt/Equity, Altman Z-Score.
Bull Case : SQM
The strongest argument for SQM centers on PEG Ratio, Operating Margin, Revenue Growth. Profitability is solid with margins at 15.4% and operating margin at 41.1%. Revenue growth of 69.8% demonstrates continued momentum.
Bear Case : BGLC
The primary concerns for BGLC are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : SQM
The primary concerns for SQM are P/E Ratio.
Key Dynamics to Monitor
BGLC profiles as a turnaround stock while SQM is a growth play — different risk/reward profiles.
BGLC carries more volatility with a beta of 2.19 — expect wider price swings.
SQM is growing revenue faster at 69.8% — sustainability is the question.
SQM generates stronger free cash flow (679M), providing more financial flexibility.
Bottom Line
SQM scores higher overall (74/100 vs 26/100), backed by strong 15.4% margins and 69.8% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BioNexus Gene Lab Corp Common stock
BASIC MATERIALS · SPECIALTY CHEMICALS · USA
BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.
Sociedad Quimica y Minera de Chile SA ADR B
BASIC MATERIALS · SPECIALTY CHEMICALS · USA
Sociedad Qumica y Minera de Chile SA produces and distributes specialty plant nutrients, iodine and its derivatives, lithium and its derivatives, potassium chloride and sulfate, industrial chemicals and other products and services worldwide. The company is headquartered in Santiago, Chile.
Compare with Other SPECIALTY CHEMICALS Stocks
Want to dig deeper into these stocks?